en |
FROM THE EDITOR
Martin Playne
Abstract
Biotechnology has certainly come of age in the last two years: its own stock exchange index, a daily prominence in the business pages of all major newspapers, frequent articles on GM foods in the first pages of most newspapers, a regular topic in current affairs on television, and, importantly, a steady stream of new and successful products in the marketplace. Australia, of course, can only mirror these happenings in quite a small way. We are a nation of less than 20 million people, within a world population of some 6 billion. We are a nation with educational and research facilities of world standing. We play our share in quality scientific publications, and we have some excellent biotechnology companies, but we are only a few per cent of the world's activity in biotechnology...
|